Glucocorticoids and COVID-19
Authors:
- 13 October 2022
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 185, 106511
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN- 202039WMFP)
- Israel Science Foundation (3933/19)
- University of Perugia
This publication has 177 references indexed in Scilit:
- Glucocorticoids inhibit dendritic cell maturation induced by Toll-like receptor 7 and Toll-like receptor 8Journal of Leukocyte Biology, 2011
- The glucocorticoid receptor: Pivot of depression and of antidepressant treatment?Psychoneuroendocrinology, 2011
- Glucocorticoid dysregulation of natural killer cell function through epigenetic modificationBrain, Behavior, and Immunity, 2011
- Molecular mechanism of glucocorticoid resistance in inflammatory bowel diseaseWorld Journal of Gastroenterology, 2011
- Corticosteroids and ARDS: A review of treatment and prevention evidenceLung India, 2011
- Saturated‐efferocytosis generates pro‐resolving CD11blow macrophages: Modulation by resolvins and glucocorticoidsEuropean Journal of Immunology, 2010
- Asthma: Clinical expression and molecular mechanismsJournal of Allergy and Clinical Immunology, 2010
- Multiple sclerosisThe Lancet, 2008
- Development of specific antibody andin vivo response to antigen in different rat strains: Effect of dexamethasone and importance of endogenous corticosteroidsInflammation Research, 1993
- Concanavalin A-induced glucocorticoid resistance in rat thymus cells: Decreased cytoplasmic and nuclear receptor binding of dexamethasoneJournal of Steroid Biochemistry, 1976